X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Clinical Trials

Takara Bio and Boston IVF Fertility Center Announce Partnership to Enable the Derivation of Clinical-grade hES cell lines for Cell Therapy Applications

Content Team by Content Team
21st September 2021
in Clinical Trials, Drug Development, News
Takara Bio and Boston IVF Fertility Center Announce Partnership to Enable the Derivation of Clinical-grade hES cell lines for Cell Therapy Applications

Takara Bio Europe AB (TBEAB) is proud to officially announce a partnership with the Boston IVF Fertility Center (Boston IVF) headquartered in Waltham, Massachusetts, USA. This partnership gives TBEAB access to discarded starting material for the derivation of clinical-grade hES cell lines for cell therapy research. “When we set off to establish our first clinical-grade hES cell line, we needed to find a partner that would accept the stringent donor and sourcing criteria”, said Kristina Runeberg, Site Head/Senior Director Corporate Development at TBEAB. “We were fortunate to find Boston IVF which has both the know-how and capabilities to fulfill the high regulatory demands required for this project. Through our initial collaboration, we were able to generate our first clinical-grade hES cell line which has recently been made available to cell therapy researchers through a new out-licensing program”.

This partnership also gives Boston IVF and the donor couples the opportunity to make compassionate use of surplus material that would otherwise be discarded. “While our main focus is on reproductive medicine and our world-renowned infertility treatment services, we also want to facilitate research that can help patients who are suffering from chronic or untreatable conditions,” said Denny Sakkas, CSO at Boston IVF. “We are excited to continue to work with TBEAB and help them to support innovative cell therapy researchers across the world.”

Learn more about TBEAB’s clinical-grade hES cell line derivation capabilities here. These services are also available in North America through Takara Bio USA, Inc.

Takara Bio Europe AB
Takara Bio Europe AB is a wholly owned subsidiary of Takara Bio Inc. that is focused on stem cell-derived products and services for cell therapy, drug discovery, and disease modeling applications, under the Cellartis brand. The company possesses broad expertise in human pluripotent stem cells, including both hiPS and hES cells, and related media. Furthermore, TBE AB’s GMP facility, located in Göteborg, Sweden, operates under a manufacturing license for the establishment and banking of clinical-grade hES cell lines.

Takara Bio USA, Inc.
Takara Bio USA, Inc. is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for the life sciences, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sample preparation.

Takara Bio Inc.
Takara Bio Inc., a world leader in biotechnology research and development, offers a host of life science research solutions, from enzymes and GMP-grade reagents to contracted cell and gene therapy manufacturing services and is the developer of the RetroNectin reagent, a world standard in gene therapy protocols. Takara Bio is committed to preventing disease and improving the quality of life for all people through the use of biotechnology.

Boston IVF Fertility Center
Boston IVF is one of the largest and most experienced fertility networks in the United States, with more than 100,000 babies born since 1986. Founded as one of the nation’s first private practice IVF centers, the Boston IVF network has grown to now include over 30 reproductive endocrinologists across 30 centers throughout Massachusetts, New England, and the United States. A renowned innovator of reproductive technologies, advanced protocols, and cutting-edge research, Boston IVF has achieved numerous “firsts” in the field of reproductive care. Its scientific and research arm continues to pave the way for breakthroughs in fertility care and accredited REI Fellowship Program, has graduated more than 30 reproductive endocrinologists as part of its mission to train the next generation of fertility experts.

Previous Post

New Water Preservation Cell Promotes Elimination of Water-borne Contaminants in Laboratory Incubators for Increased Productivity

Next Post

Pharmapack Europe: Innovation, Networking and Education

Related Posts

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Clinical Trials

Cancer Clinical Trials Get A Brand New Platform In Melbourne

3rd November 2022
Next Post
Pharmapack Europe unpacks key drivers and challenges in 2020

Pharmapack Europe: Innovation, Networking and Education

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In